The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.
about
Perinatal vs genetic programming of serotonin states associated with anxiety.The effect of antidepressants on fertilityCitalopram and escitalopram plasma drug and metabolite concentrations: genome-wide associations.Classics in chemical neuroscience: diazepam (valium).Role of pill-taking, expectation and therapeutic alliance in the placebo response in clinical trials for major depression.Sexual dysfunction associated with second-generation antidepressants in patients with major depressive disorder: results from a systematic review with network meta-analysis.Evidence-based psychological treatments for mental disorders: modifiable barriers to access and possible solutions.Geographic region and racial variations in polypharmacy in the United StatesAntidepressant Use in the Elderly Is Associated With an Increased Risk of Dementia.Fast-scan cyclic voltammetry analysis of dynamic serotonin reponses to acute escitalopram.National trends in off-label use of atypical antipsychotics in children and adolescents in the United States.Evaluation of Overactive Bladder in Male Antidepressant Users: A Prospective Study.Emergency department burden of constipation in the United States from 2006 to 2011.2013 Statistics for global prescription medications: CNS therapeutics maintain a leading position among small molecule therapeutics.2012 trends and statistics for prescription medications in the United States: CNS therapeutics continue to hold leading positions.The top prescription drugs of 2012 globally: biologics dominate, but small molecule CNS drugs hold on to top spots.Three new olanzapine structures: the acetic acid monosolvate, and the propan-2-ol and propan-2-one hemisolvate monohydrates.Lack of relationship between plasma levels of escitalopram and QTc-interval length.A review of the pharmaceutical exposome in aquatic fauna.Citalopram Induces Reproductive Toxicity in Male Rats.Hyperprolactinemia-inducing antipsychotics increase breast cancer risk by activating JAK-STAT5 in precancerous lesions.Medications that cause weight gain and alternatives in Canada: a narrative review
P2860
Q27311047-926E0118-E536-4A69-8A89-F6B5B92FDD5CQ28385361-46FF2393-B343-46BC-BC03-3C562A75F499Q34065310-B4AA3B45-3E04-44BC-B963-881C1A60C586Q34405394-DD4583C1-0249-4914-8FEE-B02E6D3AE9D3Q34589878-3D6D9AFE-1F6F-4B10-9809-2153BF577D75Q35066804-28861C88-0BBE-49E9-A5E1-374188C368EAQ35395815-1DEE0140-CD83-40CE-A323-E0A7A3BEDCA8Q35623075-42E9D8CB-4AAA-47DD-8F62-86A2878E4E5AQ36599342-2E6265F4-396E-4DBF-86DA-A0FCB8512CE6Q36851651-2BAD49B2-987B-489A-AE4A-1E596A0917BEQ37003651-ABDCF860-239D-42C3-BC1E-1B110DF1786DQ37737694-6D47BF2C-BA32-42EF-A18D-B202707323C0Q41171717-61BFEE09-7E7B-4169-88AD-0EA1526D4584Q42345743-4BE91094-3599-4460-99BE-935B7F117C6FQ42564034-898E0A61-7A28-4771-861A-5DE9809B1570Q43119496-8A2F3DFD-F1D5-4CC1-B848-0255D1E0BF89Q44585162-C807F090-C3BA-44A5-A159-B01D73097DBBQ47819968-BF67AE56-B29A-47DC-9541-71E2E88AC226Q53073985-181275FF-EFA8-4E42-AFC4-16A46DF392C4Q54394305-0E83D6E7-A04D-45A3-A6B4-770F94460B0CQ54978736-4BB50C6D-2819-4073-B775-609117334663Q58729864-E16589E5-C438-444C-A750-E91FCED81273
P2860
The top prescription drugs of 2011 in the United States: antipsychotics and antidepressants once again lead CNS therapeutics.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
The top prescription drugs of ...... e again lead CNS therapeutics.
@en
The top prescription drugs of ...... e again lead CNS therapeutics.
@nl
type
label
The top prescription drugs of ...... e again lead CNS therapeutics.
@en
The top prescription drugs of ...... e again lead CNS therapeutics.
@nl
prefLabel
The top prescription drugs of ...... e again lead CNS therapeutics.
@en
The top prescription drugs of ...... e again lead CNS therapeutics.
@nl
P356
P1476
The top prescription drugs of ...... e again lead CNS therapeutics.
@en
P2860
P304
P356
10.1021/CN3000923
P577
2012-08-01T00:00:00Z